TRAPPC9 Antibody (8A2) [FITC]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-43052F

Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Human
Applications
ELISA, Immunohistochemistry, Western Blot
Label
FITC (Excitation = 495 nm, Emission = 519 nm)
Antibody Source
Monoclonal Mouse IgG1 Clone # 8A2
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
trafficking protein particle complex 9 - (Uniprot# Q96Q05)
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Applications for TRAPPC9 Antibody (8A2) [FITC]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Immunohistochemistry
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: TRAPPC9
Alternate Names
IKBKBBP, IKK2 binding protein, KIAA1882IBP, MRT13MGC4769, NIBPMGC4737, NIK- and IKBKB-binding protein, NIK and IKK-beta binding protein, T1, trafficking protein particle complex 9, trafficking protein particle complex subunit 9, TRAPP 120 kDa subunit, TRS120, Tularik gene 1 protein
Gene Symbol
TRAPPC9
Additional TRAPPC9 Products
Product Documents for TRAPPC9 Antibody (8A2) [FITC]
Product Specific Notices for TRAPPC9 Antibody (8A2) [FITC]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...